 Antiplatelet antithrombotic effects platelet glycoprotein IIb/IIIa GPIIb/IIIa inhibition arginine-glycine-aspartic acid-serine RGDS arginine-glycine-aspartic acid RGD O-me Arginine-glycine-aspartic acid RGD minimal sequence fibrinogen recognition binding glycoprotein IIb/IIIa platelet receptor aggregation Analogs tetrapeptides RGD sequence fibrinogen platelets vitro analog arginine-glycine-aspartic acid-phenylalanine phenylalanine O-methyltyrosine study biological activities actions tetrapeptide arginine-glycine-aspartic acid-serine RGDS natural sequences fibrinogen alpha chain platelets vitro potent RGDS fibrinogen binding microM RGDS microM ADP-induced aggregation human platelet-rich plasma microM RGDS microM thrombin-induced aggregation washed human platelets microM RGDS microM rats collagen-induced thrombocytopenia mg/kg whereas RGDS response mg/kg thrombus formation rat carotid artery dose-dependent fashion effects RGDS biphasic RGDS thrombus formation doses effect doses dogs min ex vivo collagen-induced aggregation mg/kg/min data potent inhibitor platelet aggregation platelet-dependent thrombus formation